(Q36287691)

English

Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Mariana Chavez-MacGregor

4

object named as

Mariana Chavez-MacGregor

1 reference

Europe PubMed Central

13 August 2017

PMC publication ID

Funda Meric-Bernstam

6

object named as

Funda Meric-Bernstam

1 reference

Europe PubMed Central

13 August 2017

PMC publication ID

George R Blumenschein

12

object named as

George R Blumenschein

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Ana Maria Gonzalez-Angulo

1

object named as

Ana M Gonzalez-Angulo

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Gabriel N Hortobagyi

8

object named as

Gabriel N Hortobagyi

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Gordon B. Mills

10

object named as

Gordon B Mills

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Huiqin Chen

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Meghan S Karuturi

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Spyrus Tsavachidis

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Kim-Anh Do

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Patricia A Thompson

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Melissa L Bondy

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

26 June 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

119

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

7-15

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

PI3K pathway-directed therapeutic strategies in cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Targeting the mTOR signaling network for cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Novel therapeutic inhibitors of the c-Met signaling pathway in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Exploiting the PI3K/AKT pathway for cancer drug discovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Somatic mutation and gain of copy number of PIK3CA in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

c-Met: structure, functions and potential for therapeutic inhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Dysregulation of Met receptor tyrosine kinase activity in invasive tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Molecular cloning and expression of human hepatocyte growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

Evidence for the identity of human scatter factor and human hepatocyte growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

30 September 2017

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

29 June 2018

Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

29 June 2018

Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

29 June 2018

Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461089

29 June 2018

The hepatocyte growth factor regulatory factors in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27608

21 January 2018

C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27608

21 January 2018

Expression of c-met is a strong independent prognostic factor in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27608

21 January 2018

Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22736407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocytes and scatter factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22736407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/22736407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-met mRNA overexpression in human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22736407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22736407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.27608

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36287691&oldid=1855640739"